Literature DB >> 7363908

Gaucher disease--Norrbottnian type. I. General clinical description.

S Dreborg, A Erikson, B Hagberg.   

Abstract

We report follow-up studies of 22 cases of the Norrbottnian type of Gaucher disease ("type III"). The series was divided into 2 main groups of families depending on their birth province (Norrbotten, Västerbotten). The distribution and types of organ manifestations and complications were the same in both groups, each of which was considered to be genotypically homogeneous. The severity of the clinical symptoms and signs and the course of the disease differed markedly not only between families but also between siblings. Splenectomy accelerated deterioration, particularly with regard to skeletal and central nervous system manifestations. On a clinical basis it is concluded that the Norrbottnian type of Gaucher disease, which has now been diagnosed in about 40 cases, is probably due to a unique mutation which may have happened several hundred of years ago in northern Sweden.

Entities:  

Mesh:

Year:  1980        PMID: 7363908     DOI: 10.1007/bf00441578

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  22 in total

1.  Pulmonary findings in Gaucher's disease.

Authors:  A H Wolson
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1975-04

2.  METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.

Authors:  R O BRADY; J N KANFER; D SHAPIRO
Journal:  Biochem Biophys Res Commun       Date:  1965-01-18       Impact factor: 3.575

3.  Neurological signs in a juvenile form of Gaucher's disease.

Authors:  K M HERRLIN; P O HILLBORG
Journal:  Acta Paediatr       Date:  1962-03       Impact factor: 2.299

4.  [Gaucher's disease in Norrbotten].

Authors:  P O HILLBORG
Journal:  Nord Med       Date:  1959-02-19

5.  Skeletal manifestations of Gaucher's disease with some unusual findings.

Authors:  B STRICKLAND
Journal:  Br J Radiol       Date:  1958-05       Impact factor: 3.039

6.  Skeletal manifestations and treatment of Gaucher's disease. Review of twenty cases.

Authors:  H C Amstutz; E J Carey
Journal:  J Bone Joint Surg Am       Date:  1966-06       Impact factor: 5.284

7.  The motor age test: measurement of motor handicaps in children with neuromuscular disorders such as cerebral palsy.

Authors:  M K JOHNSON; F N ZUCK; K WINGATE
Journal:  J Bone Joint Surg Am       Date:  1951-07       Impact factor: 5.284

8.  Attempt at enzyme replacement by organ transplantation: renal transplantation in Gaucher disease.

Authors:  C G Groth; H Collste; S Dreborg; G Håkansson; G Lundgren; L Svennerholm
Journal:  Transplant Proc       Date:  1979-06       Impact factor: 1.066

9.  Gaucher's disease: neurologic disorder in adult siblings.

Authors:  J D Miller; R McCluer; J N Kanfer
Journal:  Ann Intern Med       Date:  1973-06       Impact factor: 25.391

10.  Juvenile Gaucher's disease with horizontal gaze palsy in three siblings.

Authors:  J H Tripp; B D Lake; E Young; J Ngu; E M Brett
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-05       Impact factor: 10.154

View more
  31 in total

1.  Reactions of vessel walls and brain parenchyma to the accumulation of Gaucher cells in the Norrbottnian type (type III) of Gaucher disease.

Authors:  N G Conradi; H Kalimo; P Sourander
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 2.  Gaucher disease.

Authors:  Aabha Nagral
Journal:  J Clin Exp Hepatol       Date:  2014-04-21

Review 3.  Multi-system disorders of glycosphingolipid and ganglioside metabolism.

Authors:  You-Hai Xu; Sonya Barnes; Ying Sun; Gregory A Grabowski
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

Review 4.  A severity scoring tool to assess the neurological features of neuronopathic Gaucher disease.

Authors:  E H Davies; R Surtees; C DeVile; I Schoon; A Vellodi
Journal:  J Inherit Metab Dis       Date:  2007-09-16       Impact factor: 4.982

5.  Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry.

Authors:  Anna Tylki-Szymańska; Ashok Vellodi; Amal El-Beshlawy; J Alexander Cole; Edwin Kolodny
Journal:  J Inherit Metab Dis       Date:  2010-01-19       Impact factor: 4.982

6.  Complex alleles of the acid beta-glucosidase gene in Gaucher disease.

Authors:  T Latham; G A Grabowski; B D Theophilus; F I Smith
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

7.  Clinical and molecular characteristics of Japanese Gaucher disease.

Authors:  Y Eto; H Ida
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

8.  Hematological findings in the Norrbottnian type of Gaucher disease.

Authors:  E Tibblin; S Dreborg; A Erikson; G Håkansson; L Svennerholm
Journal:  Eur J Pediatr       Date:  1982-11       Impact factor: 3.183

9.  Gaucher disease: heterologous expression of two alleles associated with neuronopathic phenotypes.

Authors:  M E Grace; A Berg; G S He; L Goldberg; M Horowitz; G A Grabowski
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

10.  Effect of splenectomy on destructive bone changes in children with chronic (Type I) Gaucher disease.

Authors:  A Ashkenazi; R Zaizov; Y Matoth
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.